What is CVE-2025-2229?

CVE-2025-2229 is a high-severity vulnerability in Philips Intellispace Cardiovascular (Iscv), classified under CWE-1391. CVSS score: 7.7/10. Published 2025-03-13.

How severe is CVE-2025-2229?

High severity. CVSS v3 base score is 7.7 out of 10.

Vulnerability in Philips Intellispace Cardiovascular (Iscv)

CVE-2025-2229

A token is created using the username, current date/time, and a fixed AES-128 encryption key, which is the same across all installations.

EPSS: 0.000 (10.7th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 7.7 (High). Vector: CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N.

Affected products

Philips Intellispace Cardiovascular (Iscv) — versions 0

Weakness classification (CWE)

CWE-1391

References

www.cisa.gov/news-events/ics-medical-advisories/icsma-25-072-01
www.philips.com/a-w/security/security-advisories.html

Frequently asked questions

What is CVE-2025-2229?: CVE-2025-2229 is a high-severity vulnerability in Philips Intellispace Cardiovascular (Iscv), classified under CWE-1391. CVSS score: 7.7/10. Published 2025-03-13.
How severe is CVE-2025-2229?: High severity. CVSS v3 base score is 7.7 out of 10.